Stock Events

Enzo Biochem 

€1
2
+€0+0% Friday 06:56

統計

當日最高
1
當日最低
1
52週最高
-
52週最低
-
成交量
0
平均成交量
-
市值
54.55M
市盈率
1.22
股息收益率
-
股息
-

收益

13Jun確認
Q3 2022
Q3 2022
Q4 2022
Q1 2023
Q3 2023
Q4 2023
Q1 2024
-0.31
-0.22
-0.13
-0.04
預期每股收益
N/A
實際每股收益
-0.04

人們還關注

此列表基於在 Stock Events 上關注 EZB.F 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.
Show more...
首席執行官
Ms. Kara Cannon
員工
179
國家
US
ISIN
US2941001024
WKN
000865607

上市公司